HumanCloning.org

HumanCloning.org

Home
Forum
Human Cloning Foundation Hails British Scientists
Paralyzed
Walk Again

Childless Couples
Essays
The Benefits of
Human Cloning

All the Reasons to
Clone Human Beings

The Top Ten Myths
about Human Cloning

Human Cloning is the Cure for Infertility
Infertility is
a Disease

Books
People
Reports
Archives
Feedback
Donate
Links
Website Links
About Us
Contact Us
Site history
Site Map
Past Books of the Month
John Kunich's Books
Copyright
Archives New to Old
Archives Old to New


Illegal Beings: Human Clones

Patient-specific embryonic stem cells derived from human SCNT blasto

Hwang WS, Roh SI, Lee BC, Kang SK, Kwon DK, Kim S, Kim SJ, Park SW, Kwon HS, Lee CK, Lee JB, Kim JM, Ahn C, Paek SH, Chang SS, Koo JJ, Yoon HS, Hwang JH, Hwang YY, Park YS, Oh SK, Kim HS, Park JH, Moon SY, Schatten G

Science. 2005 Jun 17;308(5729):1777-83. Epub 2005 May 19..

College of Veterinary Medicine, Seoul National University, Seoul 151-742, Korea. hwangws@snu.ac.kr

Patient-specific, immune-matched human embryonic stem cells (hESCs) are anticipated to be of great biomedical importance for studies of disease and development and to advance clinical deliberations regarding stem cell transplantation. Eleven hESC lines were established by somatic cell nuclear transfer (SCNT) of skin cells from patients with disease or injury into donated oocytes. These lines, nuclear transfer (NT)-hESCs, grown on human feeders from the same NT donor or from genetically unrelated individuals, were established at high rates, regardless of NT donor sex or age. NT-hESCs were pluripotent, chromosomally normal, and matched the NT patient's DNA. The major histocompatibility complex identity of each NT-hESC when compared to the patient's own showed immunological compatibility, which is important for eventual transplantation. With the generation of these NT-hESCs, evaluations of genetic and epigenetic stability can be made. Additional work remains to be done regarding the development of reliable directed differentiation and the elimination of remaining animal components. Before clinical use of these cells can occur, preclinical evidence is required to prove that transplantation of differentiated NT-hESCs can be safe, effective, and tolerated.
Previous Abstract  Reference new to old  Next Abstract





This Message is being posted for educational purposes, as well as for comment and criticism, by the visitors to the HumanCloning.org Foundation website (http://www.humancloning.org ).



Disclaimer: This abstract is being posted for educational purposes, as well as for comment and criticism, by the visitors to the Human Cloning Foundation website (www.HumanCloning.org ). This abstract is representative of a larger article that is indexed on Medline.

The Human Cloning Foundation was established February, 1988. .




Who's Afraid of Human Cloning?



Disease Prevention and Treatment